Oral pathogen candida in patients under antineoplastic therapies

• Principais autores: Martha Rebolledo-Cobos (Autor), Marisol Sánchez-Molina (Autor)
• Formato: Livro
• Publicado em: Universidad de Antioquia, 2018-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Cancer control treatments are aimed at prolonging patient survival, but they also trigger inevitable and irreversible side effects, often infectious in nature, complicating the prognosis of the oncological disease. These include the pathogenic behavior of Candida, with Albicans being its most common...